Overview

A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis

Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
A multicenter,randomized,single-blind, placebo-controlled,phase 4 clinical trial to evaluate the efficacy and safety of andrographolide sulfonate in patients with acute exacerbation of chronic bronchitis
Phase:
Phase 4
Details
Lead Sponsor:
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Treatments:
Andrographolide